This is a demo store. No orders will be fulfilled.

Risedronate Sodium - ≥98%, high purity , Farnesyl diphosphate synthase inhibitor, CAS No.115436-72-1, Farnesyl diphosphate synthase inhibitor

    Grade & Purity:
  • ≥98%
In stock
Item Number
R129954
Grouped product items
SKU Size
Availability
Price Qty
R129954-50mg
50mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$31.90
R129954-250mg
250mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$103.90
R129954-1g
1g
3
$309.90
R129954-5g
5g
3
$1,030.90
R129954-25g
25g
2
$3,434.90

Osteoclast-mediated bone resorption inhibitor

View related series
Parasite (997)

Basic Description

Synonyms AC-20120 | Acrel | D00942 | H11438 | Sodium trihydrogen (1-hydroxy-2-(3-pyridyl)ethylidene)diphosphonate | DRFDPXKCEWYIAW-UHFFFAOYSA-M | Risedronate (sodium) | Risedronate sodium 2.5-hydrate, European Pharmacopoeia (EP) Reference Standard | Risedronate so
Specifications & Purity ≥98%
Biochemical and Physiological Mechanisms Risedronate sodium is a pyridinyl biphosphonate which inhibits osteoclast-mediated bone resorption. Risedronate sodium is an inhibitor of FDPS.Osteoclast-mediated bone resorption inhibitor. Promotes osteoblast differentiation and reduces osteocyte apoptos
Storage Temp Store at 2-8°C
Shipped In
Wet ice
This product requires cold chain shipping. Ground and other economy services are not available.
Action Type INHIBITOR
Mechanism of action Farnesyl diphosphate synthase inhibitor
Note Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

Risedronate Sodium is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget's disease of bone.
A pyridinyl biphosphonate.

Taxonomic Classification

Taxonomy Tree

Kingdom Organic compounds
Superclass Organic acids and derivatives
Class Organic phosphonic acids and derivatives
Subclass Bisphosphonates
Intermediate Tree Nodes Not available
Direct Parent Bisphosphonates
Alternative Parents Pyridines and derivatives  Organic phosphonic acids  Heteroaromatic compounds  Azacyclic compounds  Organopnictogen compounds  Organophosphorus compounds  Organooxygen compounds  Organonitrogen compounds  Organic zwitterions  Organic sodium salts  Organic oxides  Hydrocarbon derivatives  
Molecular Framework Aromatic heteromonocyclic compounds
Substituents Bisphosphonate - Pyridine - Organophosphonic acid - Heteroaromatic compound - Organoheterocyclic compound - Organic alkali metal salt - Azacycle - Organic nitrogen compound - Organic sodium salt - Organic salt - Organic zwitterion - Organopnictogen compound - Organophosphorus compound - Organooxygen compound - Organonitrogen compound - Organic oxygen compound - Organic oxide - Hydrocarbon derivative - Aromatic heteromonocyclic compound
Description This compound belongs to the class of organic compounds known as bisphosphonates. These are organic compounds containing two phosphonate groups linked together through a carbon atoms.
External Descriptors Not available

Associated Targets(non-human)

rep Replicase polyprotein 1ab (378 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Names and Identifiers

Pubchem Sid 504762908
Pubchem Sid Url https://pubchem.ncbi.nlm.nih.gov/substance/504762908
IUPAC Name sodium;hydroxy-(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphinate
INCHI InChI=1S/C7H11NO7P2.Na/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6;/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15);/q;+1/p-1
InChIKey DRFDPXKCEWYIAW-UHFFFAOYSA-M
Smiles C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)[O-].[Na+]
Isomeric SMILES C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)[O-].[Na+]
WGK Germany 3
RTECS SZ8567200
Alternate CAS 105462-24-6,329003-65-8
PubChem CID 4194514
Molecular Weight 305.09

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

6 results found

Lot Number Certificate Type Date Item
K2211794 Certificate of Analysis Aug 22, 2024 R129954
K2211802 Certificate of Analysis Aug 22, 2024 R129954
K2211784 Certificate of Analysis Aug 22, 2024 R129954
K2329084 Certificate of Analysis Dec 04, 2023 R129954
K2329085 Certificate of Analysis Dec 04, 2023 R129954
K1509087 Certificate of Analysis May 10, 2023 R129954

Chemical and Physical Properties

Solubility DMSO Water 2 mg/mL Ethanol;Soluble in water, insoluble in ethanol
Sensitivity Moisture and heat sensitive
Molecular Weight 305.090 g/mol
XLogP3
Hydrogen Bond Donor Count 4
Hydrogen Bond Acceptor Count 8
Rotatable Bond Count 4
Exact Mass 304.983 Da
Monoisotopic Mass 304.983 Da
Topological Polar Surface Area 151.000 Ų
Heavy Atom Count 18
Formal Charge 0
Complexity 375.000
Isotope Atom Count 0
Defined Atom Stereocenter Count 0
Undefined Atom Stereocenter Count 1
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
The total count of all stereochemical bonds 0
Covalently-Bonded Unit Count 2

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.